Your browser doesn't support javascript.
loading
Do cerebrovascular risk factors impact the clinical expression of idiopathic isolated adult-onset dystonia?
Mascia, Marcello Mario; Belvisi, Daniele; Esposito, Marcello; Pellicciari, Roberta; Trinchillo, Assunta; Terranova, Carmen; Bertino, Salvatore; Avanzino, Laura; Di Biasio, Francesca; Bono, Francesco; Laterza, Vincenzo; Lettieri, Christian; Eleopra, Roberto; Fabbrini, Giovanni; Barbero, Pierangelo; Bertolasi, Laura; Altavista, Maria Concetta; Erro, Roberto; Ceravolo, Roberto; Castagna, Anna; Zibetti, Maurizio; Bentivoglio, Anna Rita; Cossu, Giovanni; Magistrelli, Luca; Scaglione, Cesa; Albanese, Alberto; Cotelli, Maria Sofia; Misceo, Salvatore; Pisani, Antonio; Schirinzi, Tommaso; Maderna, Luca; Squintani, Giovanna; Berardelli, Alfredo; Defazio, Giovanni.
Afiliação
  • Mascia MM; Neurology Unit, University Hospital of Cagliari, Cagliari, Italy. Electronic address: marcello.mas@tiscali.it.
  • Belvisi D; Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy; IRCCS Neuromed, Pozzilli, Italy.
  • Esposito M; Clinical Neurophysiology Unit, Cardarelli Hospital, Naples, Italy.
  • Pellicciari R; Department of Translational Biomedicine and Neuroscience, University of Bari, Bari, Italy.
  • Trinchillo A; Department of Neurosciences, Reproductive Sciences and Odontostomatology, "Federico II" University, Naples, Italy.
  • Terranova C; Department of clinical and Experimental Medicine, University of Messina, Messina, Italy.
  • Bertino S; Department of clinical and Experimental Medicine, University of Messina, Messina, Italy.
  • Avanzino L; Department of Experimental Medicine, Section of Human Physiology, University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Di Biasio F; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Bono F; Center for Botulinum Toxin Therapy, Neurologic Unit, A.O.U. Mater domini, Catanzaro, Italy.
  • Laterza V; Center for Botulinum Toxin Therapy, Neurologic Unit, A.O.U. Mater domini, Catanzaro, Italy.
  • Lettieri C; Neurology Unit, University Hospital S.Maria della Misericordia, Udine, Italy.
  • Eleopra R; Neurology Unit, University Hospital S.Maria della Misericordia, Udine, Italy; Neurology Unit 1, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Fabbrini G; Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy; IRCCS Neuromed, Pozzilli, Italy.
  • Barbero P; Neurology Unit, Mauriziano Umberto I Hospital, Turin, Italy.
  • Bertolasi L; Neurologic Unit, University Hospital, Verona, Italy.
  • Altavista MC; Neurology Unit, San Filippo Neri Hospital ASL Roma 1, Rome, Italy.
  • Erro R; Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana" University of Salerno, Salerno, Italy.
  • Ceravolo R; Neurology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Castagna A; IRCCS Fondazione Don Carlo Gnocchi Onlus, Milan, Italy.
  • Zibetti M; Department of Neuroscience 'Rita Levi Montalcini', University of Turin, Turin, Italy.
  • Bentivoglio AR; Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy; Institute of Neurology, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Cossu G; Neurology Service and Stroke Unit, Department of Neuroscience, AO Brotzu, Cagliari, Italy.
  • Magistrelli L; Movement Disorders Centre, Neurology Unit, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy; PhD programme in clinical and Experimental Medicine and Medical Humanities, University of Insubria, Varese, Italy.
  • Scaglione C; IRCCS Institute of Neurological Sciences, Bologna, Italy.
  • Albanese A; Department of Neurology, IRCCS, Istituto Clinico Humanitas, Rozzano, Milan, Italy.
  • Cotelli MS; Neurology Unit (ASST Valcamonica) Esine, Brescia, Italy.
  • Misceo S; Neurology Unit, San Paolo Hospital, Bari, Italy.
  • Pisani A; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy; IRCCS Mondino Foundation, Pavia, Italy.
  • Schirinzi T; Department of Systems Medicine, University of Rome 'Tor Vergata', Rome, Italy.
  • Maderna L; Department of Neurology and Laboratory of Neuroscience, IRCCS, Istituto Auxologico Italiano, Milan, Italy.
  • Squintani G; Neurology Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Berardelli A; Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy; IRCCS Neuromed, Pozzilli, Italy.
  • Defazio G; Department of Translational Biomedicine and Neuroscience, University of Bari, Bari, Italy.
Parkinsonism Relat Disord ; 115: 105851, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37717501
ABSTRACT

BACKGROUND:

Although acquired dystonia may develop following ischaemic/haemorrhagic stroke, the relationship between cerebrovascular disease and idiopathic dystonia has been poorly investigated. This cross sectional study aimed at evaluating the impact of cerebrovascular risk factors on the clinical expression of idiopathic adult onset dystonia (IAOD), with reference to dystonia localization and dystonia-associated features.

METHODS:

Data were obtained from the Italian Dystonia Registry. Patients with IAOD were stratified into two groups according to the presence of diabetes mellitus and/or arterial hypertension and/or dyslipidemia and/or heart disease. The two groups were compared for demographic features, dystonia phenotype, and dystonia-associated features (sensory trick, tremor, eye symptoms in blepharospasm, and neck pain in cervical dystonia).

RESULTS:

A total of 1108 patients participated into the study. Patients who reported one cerebrovascular factor or more (n = 555) had higher age and longer disease duration than patients who did not. On multivariable logistic regression analysis, blepharospasm was the only localization, and sensory trick was the only dystonia-associated feature that was significantly associated with cerebrovascular risk factors. Linear regression analysis showed that the strength of the association between cerebrovascular factors and blepharospasm/sensory trick increased with increasing the number of cerebrovascular factors per patient.

CONCLUSIONS:

Results of the present study showed that cerebrovascular risk factors may be associated with specific features of IAOD that is development of blepharospasm and sensory trick. Further studies are needed to better understand the meaning and the mechanisms underlying this association.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article